Loading viewer...
presentation
Format: PDF presentation
Dyne_July_2022_111_85111 by Dyne Therapeutics.
Let us design a presentation that delivers.
Novartis
Crestwood Midstream Partners
Dyne Therapeutics Company Overview 2023 | Muscle Disease
investor_presentation
44 Pages
Abercrombie & Fitch
Veracyte
Maravai LifeSciences
Owlet